P Zajac
Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes
Adamina M, Heberer M, Oertli D, Marti W, Feder C, Reschner A, Schumacher R, Padovan E, Zajac P, Cavazza A, Albo F, Bolli M, Spagnoli G. Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes. Br J Cancer 2004; 90:263-9.
12.01.2004Encapsulation into sterically stabilised liposomes enhances the immunogenicity of melanoma-associated Melan-A/MART-1 epitopes
12.01.2004Br J Cancer 2004; 90:263-9
Adamina Michel, Heberer M, Oertli D, Marti W R, Feder C, Reschner A, Schumacher R, Padovan E, Zajac P, Cavazza A, Albo F, Bolli M, Spagnoli G C
Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients
Zajac P, Heberer M, Schultz-Thater E, Padovan E, Noppen C, Guller U, Bolli M, Adamina M, Marti W, Oertli D, Spagnoli G. Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients. Hum Gene Ther 2003; 14:1497-510.
01.11.2003Phase I/II clinical trial of a nonreplicative vaccinia virus expressing multiple HLA-A0201-restricted tumor-associated epitopes and costimulatory molecules in metastatic melanoma patients
01.11.2003Hum Gene Ther 2003; 14:1497-510
Zajac P, Heberer M, Schultz-Thater E, Padovan E, Noppen C, Guller U, Bolli M, Adamina Michel, Marti W, Oertli D, Spagnoli G